Midwest Professional Planners Ltd (MPPL)’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-225
Closed -$7K 337
2018
Q1
$7K Buy
+225
New +$7.46K 0.01% 252

Other funds holding GHDX

Midwest Professional Planners Ltd (MPPL)'s GHDX Position: Q2 2018 in Review

Midwest Professional Planners Ltd (MPPL) sold out of Genomic Health, Inc. (GHDX) in Q2 2018, closing a stake of 225 shares — an estimated $7K sold.

Midwest Professional Planners Ltd (MPPL) first reported a position in GHDX in Q1 2018 and held it in 1 quarter. The position peaked at $7K in Q1 2018. 166 funds tracked by Wall St. Rank hold GHDX as of Q2 2018.

  • Midwest Professional Planners Ltd (MPPL) reported no remaining Genomic Health, Inc. position as of Q2 2018 after selling out during the quarter.
  • Midwest Professional Planners Ltd (MPPL) sold 225 Genomic Health, Inc. shares in Q2 2018, an estimated $7K.
  • Midwest Professional Planners Ltd (MPPL) first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 1 quarter.
  • Midwest Professional Planners Ltd (MPPL)'s Genomic Health, Inc. position peaked at $7K in Q1 2018.
  • 166 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2018.

Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q2 2018, filed 10 Aug 2018.